Dietary Supplementation on Fat Oxidation in Women with Overweight or Obesity

This study is looking at how a dietary supplement containing plant-derived phenolics, specifically N-trans-caffeoyl tyramine (NCT) and N-trans-feruloyl tyramine (NFT), affects how your body burns fat. You may be able to join if you are a woman between 18 and 50 years old and are considered overweight or have obesity (BMI between 29.0 and 40.0 kg/m2). Researchers want to see if taking 120 mg of this supplement daily for four weeks increases fat oxidation (how your body uses fat for energy) compared to a control product. The study is currently unclear on its recruitment status and plans to enroll 16 participants.

Study design
This is an interventional study with an enrollment goal of 16 participants. It is designed to compare the effects of a dietary supplement against a control product.
What's involved
You would take a dietary supplement daily for four weeks. Measurements of fat oxidation would be taken on Day 1 and Day 28 at multiple time points (Hour 0, 3, 4, 8, and 24).
Compensation
Not stated in the trial record.
Follow-up
Measurements are taken up to Day 28, which is the end of the 4-week consumption period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06548048

Dietary Supplementation on Fat Oxidation

Recruiting
NAAges 18–50InterventionalTreatment
Brightseed
~16 participants
Updated 2024-08-12 on ClinicalTrials.gov
What's tested:Dietary supplement containing plant derived phenolicsMicrocrystaline cellulose

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
% deuterium (2H) label from oxidation of d31-palmitic acid
Measured over Day 1 and Day 28 (each day measurements are done in multiple timepoints of Hour 0, Hour 3, Hour 4, Hour 8, and Hour 24)
Overweight
Obesity
1 sites across 1 states
Illinois1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

If an infection occurs during the study period, test visits will be rescheduled until signs and symptoms have resolved (at the discretion of the Clinical Investigator) at least 5 days prior to the scheduled study visits.
  • % deuterium (2H) label from oxidation of d31-palmitic acidDay 1 and Day 28 (each day measurements are done in multiple timepoints of Hour 0, Hour 3, Hour 4, Hour 8, and Hour 24)

    Percentage recovery of the deuterium (2H) label from oxidation of d31-palmitic acid to water in urine samples collected